Astrazeneca (AZN) Change in Intangibles (2009 - 2026)

Astrazeneca's Change in Intangibles history runs 18 years deep, the most recent figure standing at $120.0 million for Q2 2026.

• In Q2 2026, Change in Intangibles rose 39.53% year-over-year to $120.0 million; the TTM figure through Jun 2026 stood at $206.0 million (up 44.06% YoY), while the FY2025 annual figure was $136.0 million, up 10.57% from the prior year.
• Change in Intangibles for Q2 2026 stood at $120.0 million, up from $45.0 million in the prior quarter.
• The five-year high for Change in Intangibles was $385.0 million in Q1 2022, with the low at $1.0 million in Q3 2025.
• The 5-year median for Change in Intangibles is $45.0 million (2026), against an average of $88.8 million.
• The sharpest annual moves came in 2025 and 2026: Change in Intangibles plunged 96.88% in 2025, then surged 400.0% in 2026.
• Astrazeneca's Change in Intangibles stood at $57.0 million in 2022, then plunged by 57.89% to $24.0 million in 2023, then plunged by 33.33% to $16.0 million in 2024, then soared by 150.0% to $40.0 million in 2025, then surged by 200.0% to $120.0 million in 2026.
• Business Quant data shows AZN's Change in Intangibles at $120.0 million in Q2 2026, $45.0 million in Q1 2026, and $40.0 million in Q4 2025.